Tel: +263 242 708020, +263 242 705946 rsc@medsch.uz.ac.zw

Funding Opportunities

Improving the Early Detection of Lung Cancer Award Rising Tide/LUNGevity Request for Proposals

The Rising Tide/LUNGevity Award for Improving the Early Detection of Lung Cancer through biomarkers and imaging from the Rising Tide Foundation for Clinical Cancer Research (RTFCCR) and LUNGevity supports interventional clinical trials or clinical validation studies worldwide. Applicants must hold a doctoral degree and faculty appointment (or equivalent) with an academic institution, including research institutions that are not formally associated with a university and have completed a postdoctoral training fellowship. Applicants may be based anywhere in the world.

Award budget: up to 1,000,000 USD over 3 years.

Due date: Letters of intent are due on 12 February 2025

For more information, click: https://www.risingtide-foundation.org/clinical-cancer-research-science-of-early-detection-rising-tide-lungevity-award/

 

Climate and Health Award: Advancing climate mitigation solutions with health co-benefits in low- and middle-income countries

This funding call will generate a body of evidence on the health effects of climate change mitigation interventions in low- and middle-income countries (LMICs). This call builds on Wellcome’s previous funding, Advancing climate mitigation policy solutions with health co-benefits in G7 countries https://wellcome.org/grant-funding/schemes/advancing-climate-mitigation-policy-solutions-health-co-benefits-g7-countries . This award will fund transdisciplinary research teams, led by an applicant at an LMIC-based organisation. Research funded will investigate health effects alongside the social and economic impacts of planned or implemented greenhouse gas mitigation strategies. It will reflect local priorities and produce evidence to drive positive climate and health outcomes.

Preliminary Due date: February 18, 2025

Award Budget: £500,000-£2 million per project

For more information click; https://wellcome.org/grant-funding/schemes/climate-mitigation-solutions-in-lmics

 

Request for concept notes to advance adolescent sexual and reproductive health research

The present request for concept notes is intended to advance the above priorities through research. Research can include: developing and testing a new intervention or replicating an existing intervention that has been shown to be effective in a new context (simply replicating an intervention is not in itself research). Both experimental designs and implementation research will be considered. Research can be descriptive such as undertaking a survey on knowledge, attitudes and perspectives of adolescents toward a specific issue or analyzing demographic data to answer specific questions or it can study how laws and/or policies impact populations of young people. Systematic and other types of literature reviews will not qualify in this RFP.  Pre-submission inquiries regarding the suitability of a proposal for this specific call are encouraged and can be directed to Sheri Bastien at sbastien@who.int.

Due date: February 21st:

all applications must be submitted by 11:59PM (23:59) CET (Geneva time). All applications must be submitted via email to: sbastien@who.int .

For more information, click: https://www.who.int/news-room/articles-detail/request-for-concept-notes-to-advance-adolescent-sexual-and-reproductive-health-research

 

ARDF Annual Open Grant Program

ARDF’s Annual Open grant program was established to fund research projects that develop alternative methods to advance science and replace or reduce animal use. Proposals are welcome from any nonprofit educational or research institution worldwide, although there is a preference for U.S. applications to support advancing alternatives here. Proposals are evaluated based on scientific merit and feasibility, and the potential to reduce or replace the use of animals in the near future. Proposals are considered across the fields of research, testing, or education.

Award budget: The maximum award amount is $50,000, and the historical funding rate is approximately 20%.

Due date: 28 February 2025

For more information click: https://www.ardf-online.org/ardf-grants.html

Wellcome Early-Career Awards

This scheme provides funding for early-career researchers from any discipline who are ready to develop their research identity. Through innovative projects, they will deliver shifts in understanding related to human life, health and wellbeing. By the end of the award, they will be ready to lead their own independent research programme. You can apply to this scheme if you are an early-career researcher and you are ready to design, plan and deliver your own innovative research project that aims to: advance understanding in your field and/or develop methodologies, conceptual frameworks, tools or techniques that could benefit health-related research.

Due date: February 28, 2025

Award budget: Your salary and up to £400,000 for research expenses.

For more information click; https://wellcome.org/grant-funding/schemes/early-career-awards

 

2025 Research Grant Program Request for Proposals (RFP)

Innovator Award: This special award category — a three-year grant of up to $300,000 — will support senior researchers pursuing high-impact research into OCD. The goal of the Innovator Award is to support research with the potential to revolutionize scientific understanding of OCD, accelerate progress toward new and more effective treatments, and discover ways to prevent OCD from taking hold in the first place.

Michael A. Jenike Young Investigator Awards: These are grants of up to $50,000 each. They support promising young investigators who are developing their careers while pursuing creative and impactful research projects on OCD and related disorders across a range of disciplines. To be eligible for funding, researchers must be investigating OCD and related disorders (OCD, including pediatric OCD; PANS/PANDAS; hoarding disorder; body dysmorphic disorder; or body focused repetitive behaviors). Eligible applicants must be current graduate students, or must have completed their residency or their PhD (or equivalent) on or after September 1, 2020. Applicants who are still in training must submit a letter from their mentor with their application.

Due date: 28 February 2025

For more information, click: https://iocdf.org/research/grant-program/rfp/

Global Health EDCTP3 Calls for Proposals 2025

The Global Health European & Developing Countries Clinical Trials Partnership (EDCTP3) will open new calls at the end of January 2025 to fund proposals for clinical research, capacity building, and/or networking proposals in EDCTP3’s priority areas.

The 2025 Work Programme includes four calls covering seven topics:

  • Vaccines for reducing the disease burden of Tuberculosis in sub-Saharan Africa;
  • Malaria therapeutics and clinical development of new antimalarial candidates;
  • Strategic Training Hubs covering Biostatistics, Epidemiology and Modelling:
  • Epidemic Preparedness;
  • Diarrhoeal Diseases in the context of climate and health;
  • Transformative Innovations in global health.

Due date: Submission of short proposals (1st phase) by March 2025; and full proposals (2nd phase) by September 2025.

For more information, click:

https://www.global-health-edctp3.europa.eu/funding/calls-proposals_en

 

Clinical Cancer Research

The Rising Tide Foundation for Clinical Cancer Research (RTFCCR) supports truly innovative and unique patient-centered clinical trials that have the potential to positively impact the lives of cancer patients. Our overall goal is to improve treatment options and quality of life for cancer patients by funding studies focused on detection, treatment, and survivorship. We fund phase I to phase III interventional clinical trials. We do not fund, however, basic research, phase IV trials, or observational or epidemiological studies.

Due dates: Letter of Intent is due March 9th, 2025, June 29th, 2025, November 23rd, 2025

For more information, click: https://www.risingtide-foundation.org/clinical-cancer-research-how-to-apply/

The Pandemic Fund

The Pandemic Fund announced its third Call for Proposals (3rd CfP) on December 19, 2024, with an envelope of US$500 million.  Interested eligible countries, Regional Entities, and Implementing Entities will be able to submit proposals through an online portal starting in March 2025. 

Recognizing the high demand for funding demonstrated in the first and second CfP, the 3rd CfP continues to prioritize high-impact investments in: 1) early warning and disease surveillance systems, 2) laboratory systems, and 3) strengthening human resources/public health and community workforce capacity, including workforce capacity related to human and animal health. Financing is intended for projects that will help strengthen core capacities in one or more of these three priority areas, which present the promise of generating a visible impact in terms of prevention and preparedness to effectively detect and respond to disease outbreaks.

Due date: March 2025

For more information click: https://www.thepandemicfund.org/call-for-proposals

GenScript Life Science Research Grant Program

GenScript Life Science Research Grant Program is a new initiative dedicated to supporting breakthroughs in life science research areas, including but not limited to those indicated below. This program is designed to empower researchers by providing grant funding earmarked explicitly for purchasing GenScript reagents and services.

  • Gene and Cell Therapy Development
  • Antibody Drug Discovery
  • Vaccine Development

Deadline: 15 March, 15 June, 15 September and 15 November 2025

Award budget: $100,000

For more information click: https://www.genscript.com/grantprogram.html

 

Thrasher Early Career Awards

The purpose of this program is to encourage the development of researchers in child health by awarding small grants to new researchers, helping them gain a foothold in this important area. The goal is to fund applicants who will go on to be independent investigators. The Fund will make up to 32 awards total with two funding cycles (16 awards each). The Fund is open to a wide variety of research topics. We do not focus on a particular disease, but all our funded projects deal directly with children’s health.

Award budget: Maximum of $25,000 in direct costs

Concept deadline: 18 March 2025

For more information click: https://www.thrasherresearch.org/early-career-award?lang=eng

 

Request for Proposals (RFP) Integrin beta-6 (IB6) Sigvotatug Vedotin (SV) Translational and Pre-Clinical Research

Pfizer Global Medical Grants & Partnerships (GMGP) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement, or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies. The intent of this RFP is to support non-interventional Investigator Sponsored Research projects that will advance the understanding of IB6 patterns of expression and clinical outcomes in NSCLC or explore sigvotatug vedotin’s preclinical activity.

Due date: March 20, 2025

For more information: https://click-1552564.icptrack.com/icp/relay.php?r=45085618&msgid=260991&act=3389&c=1552564&pid=924210&destination=https%3A%2F%2Fcdn.pfizer.com%2Fpfizercom%2F2025-01%2FGMG-2025-ONC-Global-IB6TranslationalPreclinical-RES-final.pdf%3FVersionId%3DzvcR0YkUuAxQHrRuunIGK4tRvFk8n2W9&cf=13590&v=0ef534bb7d69b3e12adf8fe57b8daac2103ffdeb183a3dc295723f1857120508

 

Research Grants on Education: Small

The Small Research Grants on Education Program supports education research projects that will contribute to the improvement of education, broadly conceived, with budgets up to $50,000 for projects ranging from one to five years. We accept applications three times per year. This program is “field-initiated” in that proposal submissions are not in response to a specific request for a particular research topic, discipline, design, method, or location. Our goal for this program is to support rigorous, intellectually ambitious and technically sound research that is relevant to the most pressing questions and compelling opportunities in education.

Applications Open: Mid-February, 2025

Full Proposal Deadline: Mid-April, 2025

For more information click; https://www.spencer.org/grant_types/small-research-grant

Innovations for Exceptionally Low-Cost Monoclonal Antibody (mAb) Manufacturing

The Bill & Melinda Gates Foundation and LifeArc are seeking innovative solutions to lower the cost of monoclonal antibody (mAb) manufacturing, enhancing accessibility in low- and middle-income countries. Applicants can choose between grants of up to $750,000 (Option A) for scalable mAb production innovations with an 18-month duration or smaller, flexible grants (Option B) for exploratory projects reviewed monthly. Deadlines for Option A are 31 January 2025, and 31 May 2025. This opportunity encourages proposals with scalable, impactful approaches. 
Due dates: 31 May 2025

For more information click: https://gcgh.grandchallenges.org/challenge/innovations-exceptionally-low-cost-monoclonal-antibody-mab-manufacturing

Takeda Investigator Initiated Research

The Investigator Initiated Research (IIR) program supports innovative clinical and basic science studies that address important medical and scientific questions related to our compounds and therapeutic areas of interest. For areas of interest click; https://www.takeda.com/science/research-and-development/partnerships/iir/?queryID=e9ccd12c65536eb082b568ba3398386a

The request types and definitions below are applicable for the Takeda Support Research portal. For other types of requests, please use the Takeda Support Navigator to direct you to the appropriate site

  • Clinical Research. Clinical research is a research study in which one or more human subjects are prospectively assigned to one or more interventions (which may include placebo or other control) to evaluate the effects of those interventions on health related, biomedical, or behavioral outcomes. Rare Diseases, Neuroscience, Gastroenterology and Plasma Derived Therapies (excluding US): gma.research@takeda.com

Clinical Oncology: GMAO.evidence.generation@takeda.com

Vaccines: iir.takeda.vaccines.global@takeda.com

US (excluding Oncology): US.Medical.Research@takeda.com

  • Pre-Clinical Oncology Research. Pre-Clinical Oncology Research supports research using Takeda’s proprietary oncology compounds or oncology-related mouse models, antibodies or cell lines. Requests for materials are the primary purpose of this program; funding requests are rarely approved.

Preclinical Oncology: preclinicaloncology@takeda.com

  • Pre-Clinical/Non-Clinical Non-Oncology Research. Non-clinical testing is conducted at a stage of medicines development that uses animals and/or cells or tissues. It does not involve testing in humans.

Rare Diseases, Neuroscience, Gastroenterology and Plasma Derived Therapies (excluding US): gma.research@takeda.com

Vaccines: iir.takeda.vaccines.global@takeda.com

US (excluding Oncology): US.Medical.Research@takeda.com

Due date: N/A

For more information click; https://takeda.envisionpharma.com/ienv_takeda/visiontracker/portal/login.xhtml?pgm=isr&windowId=67a&windowid=cfe

Wellcome: Mental Health Award: Leveraging longitudinal data to transform early intervention in mental health

We are funding experts to unlock the potential of longitudinal datasets and develop innovative ways of identifying anxiety, depression and/or psychosis early. Successful teams will integrate cutting-edge analytics of longitudinal data with experimental research so that, in time, people may benefit from better targeted early interventions. We will define longitudinal data as any data collected over time with a minimum of three time-points. Longitudinal datasets include, but are not limited to: cohorts; electronic health records;  data from experimental research collected over time.

Award budget: £2-5 million per project

Due date: Applications open: 23 April and close 22 July 2025

For more information, click https://wellcome.org/grant-funding/schemes/mental-health-award-leveraging-longitudinal-data-transform-early-intervention#application-process-timeline-6aa9

SWOG Early Exploration & Development (SEED) Fund

Awards are made from The Hope Foundation SEED Fund to encourage preliminary research that will potentially translate to future clinical trials or trial-associated projects (translational medicine studies) within SWOG and the National Clinical Trials Network (NCTN). These awards may assist investigators with projects that support the following types of studies: pre-clinical data, secondary data analysis from clinical trials, pilot and feasibility studies (including early-stage clinical trials), small self-contained research projects, or development of research methodology/technology.

Award budget: $50,000 direct costs

Due date: 1 July 2025

For more information, click: https://thehopefoundation.org/funding-opportunities/swog-early-exploration-development-seed-fund/

E.W. “Al” Thrasher Awards

E.W. “Al” Thrasher Awards focus on projects that are changing pediatric clinical care. Each award is a novel approach to problems plaguing pediatrics. The award is open to applications focusing on any disease or topic within the umbrella of pediatrics, both in and outside the United States.  Ideal applications for the Thrasher Award address significant health problems, offering the potential for practical solutions to these problems. Typically, the primary outcome is a health outcome in children. Solutions should be innovative and have the potential for broad applicability with low barriers to implementation. Projects with a shorter distance to clinical applicability are given priority. Hypothesis-driven research is critical, exploratory, or hypothesis-generating research will not be competitive. For projects focused on improving disease diagnosis, please ensure that there are well researched, effective treatment options available to patients upon diagnosis.

Award budget: Maximum limit of $550,000

Concept Due date: Applications open: 15 July 2025

For more information, click: https://www.thrasherresearch.org/al-thrasher-award?lang=eng

Fellowships and Scholarships

 

E-JUST TICAD 8 African Scholarships for STI – Fall 2025 Intake

Egypt-Japan University of Science and Technology (E-UST) invites applicants from African countries to apply for E-JUST postgraduate (MSc or PhD) under TICAD8 scholarship for fall 2025 international admission.

For more information; refer to the attachment.

 

Global Health EDCTP3 JU and contributing partners funded Strategic Training Hubs for Fellowships in Public Health covering Biostatistics, Epidemiology and Modelling

Following a pilot collaboration with Africa CDC for a joint fellowship call under EDCTP2, the Global Health EDCTP3 is proposing to renew the joint call for fellowships [1]. After taking stock of the lessons learnt from the first programme, a funders partnership will support a joint call, i) to increase the number of fellows trained and ii) to expand the breadth of skills offered and diversity hosting institutions involved. Thisrenewed joint call will include epidemiology and biostatistics and infectious disease modelling.

Deadline dates: 1st phase short proposals 20 March 2025 17:00:00 Brussels time; 2nd phase full proposals 02 September 2025 17:00:00 Brussels time

For more information click: https://www.global-health-edctp3.europa.eu/funding/calls-proposals_en

 

AACR-EMD Serono “I’M IN” Oncodisparity Fellowships in Lung and Urothelial Cancers

The AACR-EMD Serono “I’M IN” Oncodisparity Fellowships in Lung and Urothelial Cancers represent a joint effort to encourage and support postdoctoral or clinical research fellows to conduct cancer disparities research and to establish a successful career path in this field. The proposed research should specifically address disparities in oncology care in the area of non-small cell lung cancer (NSCLC) or advanced urothelial carcinoma care and address barriers leading to inequality of cancer care that exist in institutions and within society at large. The fellowship provides a one-year grant of $65,000 to support the salary and benefits of the fellow while working on mentored cancer disparities research project. A partial amount of funds may be designated for non-personnel expenses, such as research/laboratory supplies, equipment, publication charges for manuscripts that pertain directly to the funded project, and other research expenses.

Due date:For more information click; March 18, 2025 1:00 PM

https://www.aacr.org/grants/aacr-emd-serono-oncodisparity-fellowships-lung-and-urothelial-cancers/

 

The C.H.I.L.D.R.E.N! funding program

The C.H.I.L.D.R.E.N! funding program from the Jeffrey Modell Foundation supports research focused on children living with PI, while addressing healthcare disparities, especially in developing countries, through education, testing, diagnosis, and treatment. The focus is to investigate immunological disorders, infectious diseases, and initiatives to decrease infant mortality and ultimately improve the quality of life of children affected by Primary Immunodeficiency globally. Applications are open to primary immunodeficiency researchers at all career stages around the world. The Program provides up to 25,000 USD in funding for projects spanning up to 2 years.

Due date: Applications are accepted on a rolling basis throughout the year.

For more information, click: https://info4pi.org/medical/

 

Fulbright Foreign Student Program

The Fulbright Foreign Student Program awards scholarships to Zimbabwean university faculty and researchers for advanced degrees in the United States.  Candidates are funded for a maximum of two years.  Awards and university placements will be announced in March/April for programs beginning in August/September of each year.  Designed primarily to provide professional development and strengthen higher education, the Student Program is the largest Fulbright program in Africa.

Eligibility Requirements

  • Currently employed at a tertiary or research institution in Zimbabwe and committed to returning to work in academia upon completion of the program;
  • Completed prior academic study equivalent to at least a 4-year U.S. bachelor’s degree with a minimum 2.1 GPA or its equivalent;
  • Satisfactory test scores (TOEFL, GRE, GMAT, etc.). N.B. Test fees are paid for finalists by the Fulbright program; and

Application/Selection Process

After national selection, nominations are recommended to the Fulbright Foreign Scholarship Board for final review.  The Institute of International Education then seeks university placement of successful candidates.

Application Deadline: April 1, 2025

For more information, click: https://zw.usembassy.gov/fulbright-program/

Apply here: https://apply.iie.org/ffsp2026 

 

Applications for 2025 HIV Research Trust scholarships now open

The HIV Research Trust provides funding in resource-limited settings for early- to mid-career researchers working in all fields of HIV prevention, infection and treatment. Scholarships should enable the candidate to travel to another research unit (host institution) to acquire new skills and techniques which will develop the candidate’s career and strengthen capacity in the department in which they are based (home institution).

Examples of skills and techniques include: clinical management; clinical trial experience and practice; data and trial management; statistical expertise; acquisition of laboratory techniques and analyses; cell and molecular biology.

Scholarships of up to £15,000 GBP are available, for tuition fees, laboratory costs, materials (consumables and shipping), international travel, accommodation and subsistence. Scholarships are awarded annually, following a peer-review process led by HIV Research Trust trustees. 

Application Deadline: April 2, 2025

For more information, click: https://zealous.co/hivresearchtrust/opportunity/HIV-Research-Trust-Scholarships-2025/?dm_i=77XC%2CYJ3A%2C3BSTTR%2C4D6DF%2C1

 

Regards,

Nestlé Foundation Research Grants

The Nestlé Foundation offers different award and grant categories, some of them using a modular approach, i.e. the Pilot Grant Program represents the starting grant module for a later Full Grant Research application. The eligibility criteria as well as the Research objectives and topics have to be fulfilled independently from the award category (for further details see section “Specific information for applications”):

  1. Training Grant
  2. Pilot Grant
  3. Full Grant (small / large)

At present the Foundation’s work is primarily concerned with human nutrition research issues dealing with:

  • maternal and child nutrition, including breastfeeding and complementary feeding,
  • macro- and micronutrient deficiencies and imbalances,
  • interactions between infection and nutrition, and
  • nutrition education and health promotion.

Due date for Letter of Intent: N/A

For more information click; https://www.nestlefoundation.org/research.html

 

Global Health Research – Researcher-led bands 1 to 3

Our Global Health Research (GHR) – Researcher-led programmes are looking for applications to this new, annual funding opportunity. GHR – Researcher-led funds research that aims to improve health outcomes for the most vulnerable people in low and middle income countries (LMICs). Research must address evidence needs that are locally identified and prioritised, and must promote health equity, aligning with the aims of Sustainable Development Goal 3. Applications can span from broad, ambitious programmes of research to projects with a narrower scope. This is a two-stage funding opportunity.

Due date: 6 November 2024 at 1:00 pm

Award budget: £0.25-£7 million, over a period up to 5 years, depending on the band you apply for.

For more information click: https://www.nihr.ac.uk/funding/global-health-research-researcher-led-bands-1-3/97010

 

Call for Proposals: TANGO2 Research Foundation Grant Program

The TANGO2 Research Foundation (T2RF) research grants provide essential funding for seed or pilot research projects, fostering the exploration of groundbreaking research concepts. These awards support initial testing phases, allowing researchers to embark on smaller-scale endeavors. The emphasis lies in evaluating feasibility and refining methodologies, shaping the trajectory of potential larger-scale studies. Through this funding mechanism, we empower researchers to take innovative ideas from conception to a vital stage of validation, contributing to the advancement of knowledge and discovery. We seek to fund rigorous, high-quality research studies in efforts to fulfill our foundation’s mission enthusiastically.

Letter of Intent Due date: 8 November 2024

Award budget: Up to $25,000 for single institution & up to $50,000 for multi-institution (with an opportunity for up to an additional $25,000 with a competitive one year renewal)

For more information click: https://tango2research.org/research/grants/

 

Global Call for Collaborators – Pfizer Migraine Research 

Globally, there are more than one billion people living with migraine and it ranks among the top three most debilitating neurological diseases. While research into the etiology and treatment of migraine continues to advance, key knowledge gaps remain. The intent of this CFC is to identify investigators with innovative research ideas who want to partner and co-develop research studies with Pfizer, and potentially other investigators where multiple proposals share similar objectives and methodological approaches. In these instances, Pfizer along with the investigators, may pursue a single research study with multiple sites should all the parties agree. This CFC will be a two step process. The first step will be for investigators to submit a  Letter of Intent (LOI)  providing a high-level synopsis of the proposed project. In the second step, LOIs will be selected for further development into a research collaboration with Pfizer.

Due date: 13 November 2024 23:59 Eastern Standard Time

Award budget: $500,000

For more information click: chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https://cdn.pfizer.com/pfizercom/2024-10/Global%20CFC%20%E2%80%93%20Pfizer%20Migraine%20Research%20-%20October%202024.pdf?VersionId=P2Ud8mbnCVpjKF6N3UjAsR3lHubWh89r

 

GenScript Life Science Research Grant Program

GenScript Life Science Research Grant Program is a new initiative dedicated to supporting breakthroughs in life science research areas, including but not limited to those indicated below. This program is designed to empower researchers by providing grant funding earmarked explicitly for purchasing GenScript reagents and services.

  • Gene and Cell Therapy Development
  • Antibody Drug Discovery
  • Vaccine Development

Deadline: 15 November 2024

For more information click: https://www.genscript.com/grantprogram.html

 

Wellcome Career Development Awards

This scheme provides funding for mid-career researchers from any discipline who have the potential to be international research leaders. They will develop their research capabilities, drive innovative programmes of work and deliver significant shifts in understanding related to human life, health and wellbeing.

Due date: 24 November 2024

Award budget: The annual expenditure for a Career Development Award is usually below £250,000 excluding the applicant’s salary.

For more information click: https://wellcome.org/grant-funding/schemes/career-development-awards

 

Wellcome Discovery Awards

This scheme provides funding for established researchers and teams from any discipline who want to pursue bold and creative research ideas to deliver significant shifts in understanding related to human life, health and wellbeing.

Due date: 3 December 2024

Award budget: The average size of a Discovery Award is £3.5 million.

For more information click: https://wellcome.org/grant-funding/schemes/discovery-awards

Applied global health research: stage one

Apply for funding to support applied research that will address global health challenges and inequities.

We will accept applications of all sizes, including large research projects and small to medium-scale applications. We are looking to develop a portfolio of high-quality global research which will be diverse, promote multidisciplinarity and strengthen global health research capacity.
We encourage applications from project leads based in:

  • low and middle-income countries (LMICs)
  • UK, working in equitable partnership with LMIC researchers

Due date: 3 December 2024 4:00pm UK time

Award budget: £150,000 – £2,000,000

For more information click: https://www.ukri.org/opportunity/applied-global-health-research/

Gastrointestinal Manifestations of CF: Basic Science Projects

The intent of this request for applications is to solicit and fund projects that will improve our understanding of the biological basis for the development and progression of gastrointestinal manifestations in cystic fibrosis as well as to identify potential novel therapeutic strategies to manage and treat them. Grant applications submitted through this request for applications (RFA) must focus on basic science research projects. Proposals that include methodologies requiring human subjects or sampling of materials from human subjects will be considered under this mechanism only if the sampling method constitutes minimal patient risk (e.g., venipuncture, nasal brushings) and the sample will be utilized in basic or laboratory research. Projects using previously obtained human samples or samples collected as part of routine clinical care may be allowed; however, this should be specified clearly in the application.

Due date: 5 December 2024  5 p.m. ET

Award budget: The CF Foundation offers funding of up to $150,000 per year for up to three years

For more information click: https://www.cff.org/researchers/gastrointestinal-manifestations-cf-basic-science-projects

 

Mental Health Award: Accelerating scalable digital mental health interventions

This call will fund research to evaluate and further develop scalable digital interventions to advance early intervention in depression, anxiety and psychosis. Teams must have the research expertise required to drive the proposed research, an organisation which can take the intervention to scale (whether a company or not-for-profit) and lived experience experts. This call is open to interventions designed to lead to reductions in symptom(s) and/or functional impairments related to anxiety, depression or psychosis. We expect teams to already have a minimum viable product and feasibility data for their intervention.

Due date: 5 December 2024

Award budget: £3 to 7 million per project

For more information click: https://wellcome.org/grant-funding/schemes/digital-mental-health-interventions

HIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Institutions (R21 Clinical Trial Optional)

The goals of this program are to support locally relevant research in critical areas of HIV-associated non-communicable diseases (NCDs) at Low- and Middle-Income Country (LMIC) Institutions, to enhance research capacity, and to build a network of researchers both within and across LMICs to address this critical burden. This initiative is expected to stimulate new research on the interplay between HIV and development of NCDs in persons living with HIV (PLWH). This includes exploratory studies to uncover the extent to which HIV infection influences the etiopathogenesis of the NCDs; and to identify and develop appropriate approaches for effective diagnosis, prevention, therapeutic interventions and integrated clinical care for PLWH with the comorbid conditions. Applicants should develop their studies in keeping with the NIH HIV/AIDS Research Priorities

(https://www.oar.nih.gov/hiv-policy-and-research/research-priorities;

https://grants.nih.gov/grants/guide/notice-files/NOT-OD-20-018.html). Research teams should contain an appropriate mix of expertise to accomplish the proposed studies, including partnerships between HIV and NCD researchers who can initiate new ideas, and determine feasibility of novel approaches to understand and reduce the long-term suffering from the comorbid disorders. Applicants will also be asked to address the needs of collaborating LMIC institutions to develop capacity for carrying out research in this field.

Deadline: 9 December 2024

Award budget: The combined budget for direct costs for the two-year project period may not exceed $275,000. No more than $150,000 may be requested in any single year.

For more information click: https://grants.nih.gov/grants/guide/pa-files/PAR-23-191.html

The Confluence of Cancer Stigma and HIV Stigma in HIV-positive Individuals Diagnosed with Cancer (R21 Clinical Trial Optional)

Through this notice of funding opportunity (NOFO) as a request for applications (RFA), the National Cancer Institute (NCI) intends to support pilot/exploratory research that expands the current understanding of the confluence of cancer stigma and HIV stigma in people with HIV (PWH) diagnosed with cancer; assesses the impact of these two converging stigmas on cancer outcomes among PWH with cancer; leverages stigma reduction interventions at multiple levels to intervene on modifiable mechanisms of stigma that contribute to negative cancer outcomes among PWH with cancer; and promotes research in domestic and international contexts, focusing on regions in which the HIV-cancer burden is elevated.

Due date: 10 December 2024

Award budget: R21 applications are limited to $275,000 in direct costs for up to 2 years. No more than $200,000 may be requested in any single year.

For more information click: https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-25-012.html

 

The Confluence of Cancer Stigma and HIV Stigma in HIV-positive Individuals Diagnosed with Cancer (R01 Clinical Trial Optional)

Through this notice of funding opportunity (NOFO) as a request for applications (RFA), the National Cancer Institute (NCI) intends to support research that expands the current understanding of the confluence of cancer stigma and HIV stigma among people with HIV (PWH) diagnosed with cancer; assesses the impact of these two converging stigmas on cancer outcomes among PWH with cancer; leverages stigma reduction interventions at multiple levels to intervene on modifiable mechanisms of stigma that contribute to negative cancer outcomes among PWH with cancer; and promotes research in domestic and international contexts, focusing on regions in which the HIV-cancer burden is elevated.

Due date: 10 December 2024

Award budget: Direct costs in any single year should reflect the actual needs of the proposed project; however, budgets are limited to $500,000 Direct Costs (excluding consortium F&A) per year.

For more information click: https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-25-011.html

 

Melvin Yahr Parkinson’s Disease Clinical Research Award

The Parkinson’s Foundation is seeking proposals for its Melvin Yahr Parkinson’s Disease Clinical Research Award to foster clinical research into any aspect of Parkinson’s disease conducted by young investigators who are under-represented in current research. The goal of the award is to prepare young neurologists specializing in Parkinson’s disease for a career in clinical research. Clinician scientists are uniquely positioned to be experts in both Parkinson’s disease research and care.

Due date: 9 January 2025

Award budget: This is a 1-year award for a total of $50,000.

For more information click: https://www.parkinson.org/resources-support/professionals/resources/clinical-training-awards#PartnershipAwards

 

E.W. “Al” Thrasher Awards

E.W. “Al” Thrasher Awards focus on projects that are changing pediatric clinical care. Each award is a novel approach to problems plaguing pediatrics. The award is open to applications focusing on any disease or topic within the umbrella of pediatrics, both in and outside the United States.

Ideal applications for the Thrasher Award address significant health problems, offering the potential for practical solutions to these problems. Typically, the primary outcome is a health outcome in children. Solutions should be innovative and have the potential for broad applicability with low barriers to implementation. Projects with a shorter distance to clinical applicability are given priority. Hypothesis-driven research is critical, exploratory, or hypothesis-generating research will not be competitive.

For projects focused on improving disease diagnosis, please ensure that there are well researched, effective treatment options available to patients upon diagnosis.

Concept Due date: January 14, 2025 (Noon Mountain Time)

Award budget: The grant amount is based on the actual budgetary needs of the project. Grants are not given over $550,000.

For more information click: https://www.thrasherresearch.org/al-thrasher-award?lang=eng

 

Climate and Mental Health Award: Uncovering mechanisms between heat and mental health

This award will fund projects to advance our understanding of the biological, psychological and/or social mechanisms through which heat affects anxiety, depression and psychosis in the most impacted groups globally. Successful applications will identify relevant climate-resilient and/or mental health interventions with a realistic potential for real-world application.

Due date: 21 January 2025 17:00 (GMT)

Award budget: £1 – 3 million per project

For more information click: https://wellcome.org/grant-funding/schemes/heat-and-mental-health-award#key-dates-e140

 

Consortium for Neuroscience AD/ADRD in Low- and Middle-Income Countries (U01 Clinical Trial Not Allowed)

This Notice of Funding Opportunity (NOFO) aims to promote collaborative research programs by inviting applications to support innovative and sustainable Alzheimer’s disease (AD) and AD-related dementias (ADRD) (including frontotemporal dementia (FTD), Lewy body dementia (LBD), vascular cognitive impairment/dementia (VCID), and mixed etiology dementias (MEDs)) neuroscience research for experienced investigators in low- and middle-income countries (LMICs). These collaborative research programs are expected to contribute to the long-term goals of building sustainable AD/ADRD neuroscience capacity and research, ultimately leading to prevention and mitigation strategies for AD/ADRD in LMICs. This NOFO supports applications submitted from LMIC institutions as defined by the World Bank. LMIC scientists are expected to collaborate with scientists from the United States.

Due date: 14 February 2025

Award budget: Application budgets are limited to $400,000 in direct cost per year.

For more information click: https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-25-032.html

Small Research Grant Program for the Next Generation of Researchers in Low- and Middle-Income Countries (LMICs) for Aging and Alzheimer’s Disease (AD) and AD-Related Dementias (ADRD) Research (R03 Clinical Trial Not Allowed)

This Notice of Funding Opportunity (NOFO) invites R03 applications from institutions in low- and middle-income countries (LMICs), as defined by the World Bank, to support junior faculty investigators involved in aging and Alzheimer’s Disease (AD) and AD-related dementias (ADRD) from these institutions. The goals of this NOFO are the following::

  1. To support the aging and/or AD/ADRD research conducted by junior faculty investigators from institutions in LMICs; and
  2. To support the career development of junior faculty investigators from institutions in LMICs as future leaders in aging and AD/ ADRD.

In support of the program’s goals, this NOFO invites applications that will yield pilot data, resources, and experience for subsequent aging and AD/ADRD research projects. In addition, candidates are encouraged to seek out a supportive research environment that will achieve the goal of fostering the career development of junior investigators.

Due date: 14 February 2025

Award budget: Application budgets are limited to $100,000 in direct cost per year.

For more information click: https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-25-031.html

 

Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)

The purpose of this Funding Opportunity Announcement (FOA) is to support studies that will identify, develop, and/or test strategies for overcoming barriers to the adoption, adaptation, integration, scale-up, and sustainability of evidence-based interventions, practices, programs, tools, treatments, guidelines, and policies. Studies that promote equitable dissemination and implementation of evidence-based interventions among underrepresented communities are encouraged. Conversely, there is a benefit in understanding circumstances that create a need to stop or reduce (“de-implement”) the use of practices that are ineffective, unproven, low-value, or harmful. In addition, studies to advance dissemination and implementation research methods and measures are encouraged. Applications that focus on re-implementation of evidence-based health services (e.g. cancer screening) that may have dropped off amidst the ongoing COVID pandemic are encouraged.

Due dates: 16 February 2025

Award budget: The combined budget for direct costs for the two-year project period may not exceed $275,000. No more than $200,000 may be requested in a single year.

For more information click: https://grants.nih.gov/grants/guide/pa-files/PAR-22-109.html

Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)

The purpose of this Funding Opportunity Announcement (FOA) is to support studies that will identify, develop, and/or test strategies for overcoming barriers to the adoption, adaptation, integration, scale-up, and sustainability of evidence-based interventions, practices, programs, tools, treatments, guidelines, and policies. Studies that promote equitable dissemination and implementation of evidence-based interventions among underrepresented communities are encouraged. Conversely, there is a benefit in understanding circumstances that create a need to stop or reduce (“de-implement”) the use of practices that are ineffective, unproven, low-value, or harmful. In addition, studies to advance dissemination and implementation research methods and measures are encouraged. Applications that focus on re-implementation of evidence-based health services (e.g. cancer screening) that may have dropped off amidst the ongoing COVID pandemic are encouraged.

Due date: 16 February 2025

Award budget: A budget for direct costs of up to $50,000 per year may be requested.

For more information click: https://grants.nih.gov/grants/guide/pa-files/PAR-22-106.html

Fellowships

AAUW International Fellowships

International Fellowships have been in existence since 1917. The program provides support for women pursuing full-time graduate or postdoctoral study in the United States to women who are not U.S. citizens or permanent residents, and who intend to return to their home country to pursue a professional career.

Due date: November 15, 2024, by 11:59 p.m. Pacific Standard Time

Award budget: US$20,000 – $50,000

For more information click: https://www.aauw.org/resources/programs/fellowships-grants/international/

 

Mawazo Fellowship Programme

The Mawazo Fellowship Programme is a 15-month, non-residential fellowship. This programme is designed to build a network of African women experts who are poised to influence policy and public discourse in academia and beyond, increasing the application and implementation of practical, evidence-based ideas that drive Africa’s development.

Due date: 10 November 2024, 11.59 pm EAT

For more information click: https://mawazoinstitute.org/fellowship

2025 Fellowship applications are now open

Applications for the 2025 Ibrahim Leadership Fellowship are now open. The Ibrahim Leadership Fellowships are a 12-month programme designed to support the professional development of future African leaders. The Fellowship programme invites emerging leaders from across Africa to apply to join the 2025 cohort of MIF Fellows and make the most of this opportunity. The Ibrahim Leadership Fellowship is a flagship initiative of the Foundation that equips Fellows with technical and leadership skills and enables them to contribute directly to research and policy design at their host institutions. Past MIF Fellows come from a wide range of backgrounds, including research and advisory work in economics, trade, development, peace studies and conflict resolution. The programme aims to drive positive change and ignite innovation across Africa by providing the next generation of African leaders with practical work experience at renowned international institutions.

Due date: 20 November 2024

For more information click: https://mo.ibrahim.foundation/news/2024/2025-fellowship-applications-now-open

WomenLift Health 2025 Southern Africa Leadership Journey

This 12-month, fully-funded program empowers women to explore their authentic leadership through vulnerability and self-reflection. Participants will build inclusive and diverse networks that foster belonging, learn strategies to enhance their voice, presence, and influence, and receive support from peers, mentors, and coaches. The Leadership Journey equips participants with contextualised tools and frameworks to address individual, organisational, and societal challenges that women leaders in global health face today.

Our Signature Leadership Journey is a transformative learning experience that brings together mid- to senior-career women from various disciplines and sectors in health. It aims to instill the mindset shift needed to address the complex challenges of global public health issues today.

This program is particularly suited for women leaders who value diversity, equity, and inclusion; who recognise the importance of integrating diverse perspectives into policy and practice; and who are eager to expand their leadership presence and influence while paying it forward to others in their organisations.

Due date: 22 November 2024 at 17:00, CAT.

For more information, click: https://www.womenlifthealth.org/southern-africa-signature-leadership-journey/

Webinar

 

Two-Part Virtual Event, NIH Grants Process Primer: Application to Award

NIH is hosting a two-part event that will provide participants with the basics to help you in your role working with the NIH grants process from application preparation to award. In Part One NIH experts will introduce participants to the NIH as an organization, key components of finding the right funding opportunity, the NIH team, application, and more. In Part Two participants will have the opportunity to view demos and engage during this next-level look at tools and systems used during the application process.

Virtual event dates: November 13-14, 2024 at 1:00-4:00 pm ET

To register, click; https://grants.nih.gov/news-events/calendar-of-events/66eaef67c35c99ed5b024512

Development & Testing of Novel Interventions to Improve HIV Prevention, Treatment,
and Program Implementation for People Who Use Substances (R34 Clinical Trial
Required)
This notice of funding opportunity (NOFO) encourages formative research, intervention
development, and pilot-testing of interventions for people who use drugs. Primary outcomes
of interest include the feasibility, acceptability and safety of novel or adapted interventions
that target HIV prevention, treatment or services research. Interventions here may include
behavioral, social, or structural approaches, as well as combination biomedical and
behavioral approaches that prevent the acquisition or transmission of HIV infection, or
improve clinical outcomes for persons living with HIV.
This Notice of Funding Opportunity (NOFO) requires a Plan for Enhancing Diverse
Perspectives (PEDP)
To support basic, clinical, translational, and implementation research in the field of substance
use. To develop new knowledge and approaches for the prevention, diagnosis, and
treatment of drug use, misuse, and addiction, drug overdose, and related health outcomes,
including HIV/AIDS.
https://grants.nih.gov/grants/guide/pa-files/PAR-24-
329.html#_Section%20III.%20Eligibility%20Information
Due date May 08, 2027
HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial
Optional)
The purpose of this HEAL Initiative program is to: (1) support basic and mechanistic pain
research from R15-eligible undergraduate-focused serving institutions, health professional
schools or graduate schools; (2) promote integrated, interdisciplinary research partnerships
between Principal Investigators (PIs) from R15-eligible institutions and investigators from
U.S. domestic institutions; and (3) enhance the pain research environment at the R15-
eligible institution for health professional students, undergraduate and/or graduate students
through active engagement in pain research.
Applications in response to this notice of funding opportunity (NOFO) should include plans to
accomplish these goals. Specifically, applications should include a rigorous plan for
conducting basic and mechanistic pain research in the Research Strategy section of the
application. In addition, a research partnership between the PI’s institution and at least one
investigator from a separate U.S. domestic institution that provides resources and/or
expertise that will enhance the proposed pain research program must be included in a
separate Team Management Plan. The proposed partnership will be a sub-award
agreement(s) with at least one partnering institution, which does not need to be R15-eligible.
The budget of all sub-awards must not exceed one third of the total budget. Furthermore,
applications must include a Facilities & Other Resources document that demonstrates
active involvement of health professional students, undergraduate and/or graduate students
from the R15-eligible institution(s) in the proposed pain research projects.
https://grants.nih.gov/grants/guide/rfa-files/RFA-AT-25-
003.html#_Section%20III.%20Eligibility%20Information
Due date November 24, 2026

Secondary Analysis of Existing Datasets in Heart, Lung, and Blood Diseases and
Sleep Disorders (R21 Clinical Trial Not Allowed)
Funding Category:
Research and Development
Notice Number: PAR-25-056
Exploratory/Developmental Grants (R21)
Purpose: The goal of this funding opportunity is to stimulate the use of existing human
datasets for well-focused secondary analyses to investigate novel scientific ideas or new
models, systems, tools, methods, or technologies that have the potential for significant
impact on biomedical or biobehavioral research in areas relevant to the NHLBI mission.
Issuing Organization:
NHLBI
Application Types Allowed:
New, Resubmission, Revision
Expiration Date: January 8, 2026

Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R21
Clinical Trial Optional)
Notice Number: PAR-25-331
Funding Category:
Research and Development
Exploratory/Developmental Grants (R21)
Purpose: The purpose of this Notice of Funding Opportunity (NOFO) is to invite applications
proposing new tests, animal models, techniques, etc. to advance research on Alzheimer's
disease (AD) and its related dementias (ADRD) that need additional preliminary data with
broader dissemination to establish them for more general use in this research field. The
priority topics will be announced through a series of Notices published subsequent to this
NOFO.
Expiration Date: November 17, 2027

Funding
Opportunity
Number:

PAR-25-355

Funding
Opportunity
Title:

Multidisciplinary Studies of HIV/AIDS and Aging (R21 Clinical Trial Optional)

Agency Name: National Institutes of Health

Description: This NOFO invites applications at the intersection of HIV and aging by proposing

research that aims to meet the following objectives: 1) Improve the
understanding of biological, clinical, and socio-behavioral aspects of aging
through the lens of HIV infection and its treatment; and 2) Improve approaches
for testing, preventing, and treating HIV infection, and managing HIV-related
comorbidities, co-infections, and complications in different populations and
cultural settings by applying current aging science approaches. Proposed
research must be consistent with the HIV/AIDS Research Priorities outlined by
NIHs Office of AIDS Research (OAR), as described inNOT-OD-20-018.

Link to
Additional
Information:

https://grants.nih.gov/grants/guide/pa-files/PAR-25-355.html

CurrentClosing: Jan 07, 2027

For Expired funding opportunities:

  Click here

CONTACT US

University of Zimbabwe
Faculty of Medicine and Health Sciences
Research Management Unit
Parirenyatwa Hospital Grounds

Tel: +263 242 708020, +263 242 705946

Email address

rscsacoreoffice@gmail.com

rsc@medsch.uz.ac.zw

Website

www.uzchsrsc.ac.zw

 Twitter

ttps://twitter.com/UZCHSRSC

Linkedin

https://www.linkedin.com/in/uz-fmhs-research-support-centre-995768267/

Research Management       Unit